Nuvectis Pharma: Funding, Investors & Team (Oct 2026)
Nuvectis Pharma is a biopharmaceutical company focused on creating new targeted treatments for cancer. The company is headed by a team of experienced industry professionals who have successfully developed drugs and navigated clinical and regulatory processes. Through our expertise in selecting targets, profiling drugs, and executing clinical trials, we are working to develop a range of new products for cancer treatment.
Nuvectis Pharma has raised $116M across 2 funding rounds on record, the most recent an undisclosed round of $100M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nuvectis Pharma Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Nuvectis Pharma Funding Rounds
Nuvectis Pharma raised $15.5M in an undisclosed round announced in Feb 2025.
1.3 years later, an undisclosed round of $100M was announced in Jun 2026.
Nuvectis Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Nuvectis Pharma Funding Compared to Other Biotechnology Startups
Nuvectis Pharma's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nuvectis Pharma in Biotechnology and Fort Lee
Companies Similar to Nuvectis Pharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Nuvectis Pharma Funding FAQs
What does Nuvectis Pharma do?
Nuvectis Pharma is a biopharmaceutical company focused on creating new targeted treatments for cancer. The company is headed by a team of experienced industry professionals who have successfully developed drugs and navigated clinical and regulatory processes. Through our expertise in selecting targets, profiling drugs, and executing clinical trials, we are working to develop a range of new products for cancer treatment.
How much funding has Nuvectis Pharma raised?
Nuvectis Pharma has raised $116M across 2 rounds on record. The most recent is an undisclosed round of $100M announced in Jun 2026.
When did Nuvectis Pharma last raise funding?
Nuvectis Pharma's most recent funding round on record is an undisclosed round of $100M, announced in Jun 2026.
Who founded Nuvectis Pharma?
FundedIQ lists Ron Bentsur (Founder) at Nuvectis Pharma.
Where is Nuvectis Pharma headquartered?
Nuvectis Pharma is based in Fort Lee, New Jersey, United States.
How many employees does Nuvectis Pharma have?
Nuvectis Pharma is in the 11-50 employee band.
How does Nuvectis Pharma's funding compare to other Biotechnology startups?
Nuvectis Pharma's latest round of $100M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nuvectis Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nuvectis Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.